Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
solifenacin 10 mg
DRUG
2 trials
Sponsors
Astellas Pharma Europe Ltd.
, Mansoura University
Conditions
Benign Prostatic Hyperplasia
Overactive Bladder
Urinary Bladder Diseases
Urinary Bladder Overactive
Urologic Diseases
Phase 3
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Completed
NCT01908829
Astellas Pharma Europe Ltd.
Urinary Bladder Diseases, Urinary Bladder Overactive, Urologic Diseases
Start: 2013-07-10
End: 2014-11-25
Updated: 2024-10-31
Phase 4
Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB
NCT05494567
Mansoura University
Benign Prostatic Hyperplasia, Overactive Bladder
Start: 2021-11-08
End: 2022-08-31
Target: 60
Updated: 2022-08-10
Related Papers
PD36-02 MIRABEGRON ADD-ON TREATMENT TO SOLIFENACIN IN INCONTINENT OVERACTIVE BLADDER (OAB) PATIENTS: A RESPONDER ANALYSIS OF A RANDOMIZED, DOUBLE BLIND, PHASE 3B STUDY
The Journal of Urology
2016-03-28
Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)
European Urology
2016-03-08
181 citations